Vigilant Biosciences Announces Poster Presentation at the Boston University / Dana-Farber Head & Neck Cancer Symposium

Vigilant Biosciences Announces Poster Presentation at the Boston University / Dana-Farber Head & Neck Cancer Symposium August 7, 2018 FORT LAUDERDALE, Florida Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced today the upcoming presentation of an abstract regarding the Sylvester Comprehensive

Vigilant Biosciences Announces Agreement with Crown Dental + Medical Limited for Exclusive Distribution of the OncAlert™ Oral Cancer Product Line in New Zealand

Vigilant Biosciences Announces Agreement with Crown Dental + Medical Limited for Exclusive Distribution of the OncAlert™ Oral Cancer Product Line in New Zealand August 18, 2015 AUCKLAND, New Zealand and FORT LAUDERDALE, Florida Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced

Vigilant Biosciences, Inc. Expands Board of Directors with Esteemed Dental Professional Dr. Linda Niessen

Vigilant Biosciences, Inc. Expands Board of Directors with Esteemed Dental Professional Dr. Linda Niessen June 17, 2015 FORT LAUDERDALE, Florida Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced today the expansion of its Board of Directors with the addition of Linda

Exclusive Distribution of the OncAlert™ Oral Cancer Product Line in France, Algeria, Morocco and Tunisia

Exclusive Distribution of the OncAlert™ Oral Cancer Product Line in France, Algeria, Morocco and Tunisia June 10, 2015 FORT LAUDERDALE, Florida Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced today that it has entered into a three-year exclusive sales and marketing

Vigilant Biosciences Announces Two Poster Presentations at the 2015 AACR Annual Meeting

Vigilant Biosciences Announces Two Poster Presentations at the 2015 AACR Annual Meeting April 21, 2015 FORT LAUDERDALE, Florida Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced today the upcoming presentation of two abstracts supporting the ongoing clinical development of its OncAlert™

National Oral Cancer Awareness Survey Reveals Greater Need for Education and Screening Tools for Oral Cancer Among U.S. Adults

National Oral Cancer Awareness Survey Reveals Greater Need for Education and Screening Tools for Oral Cancer Among U.S. Adults April 1, 2015 FORT LAUDERDALE, Florida Among 1,050 U.S. consumers, the majority knows little or nothing at all about oral cancer (68 percent) and only 36 percent reported being screened for oral cancer at their last

Vigilant Biosciences Announces Agreement with Biotech-IgG AB for Exclusive Distribution of the OncAlert™ Oral Cancer Product Line in Scandinavia

Vigilant Biosciences Announces Agreement with Biotech-IgG AB for Exclusive Distribution of the OncAlert™ Oral Cancer Product Line in Scandinavia March 11, 2015 COLOGNE, Germany Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced today that it has entered into a three-year exclusive

Vigilant Biosciences Enters Agreement with BL&H Co., Ltd. for Exclusive Distribution of the OncAlert™ Oral Cancer Product Line in Korea

Vigilant Biosciences Enters Agreement with BL&H Co., Ltd. for Exclusive Distribution of the OncAlert™ Oral Cancer Product Line in Korea March 10, 2015 COLOGNE, Germany Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced today that it has entered into a five-year

Vigilant Biosciences to Exhibit and Present at International Dental Show 2015

Vigilant Biosciences to Exhibit and Present at International Dental Show 2015 March 6, 2015 MIAMI, Florida Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced today that it will debut its OncAlert™ Oral Cancer product line in Hall 4.2 Booth #N049 at

Vigilant Biosciences Closes $5.5 Million Series B Round of Funding

Vigilant Biosciences Closes $5.5 Million Series B Round of Funding February 24, 2015 MIAMI, Florida Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced today the successful completion of a $5.5 million Series B round of funding, bringing the total amount of

© 2020 Vigilant Biosciences

Follow Us

3900001 Rev2